Marshall Wace’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $283K | Buy |
20,660
+9,160
| +80% | +$125K | ﹤0.01% | 2207 |
|
|
2025
Q1 | $127K | Sell |
11,500
-124,991
| -92% | -$1.38M | ﹤0.01% | 2342 |
|
|
2024
Q4 | $1.45M | Buy |
+136,491
| New | +$1.45M | ﹤0.01% | 1451 |
|
|
2024
Q3 | – | Sell |
-42,841
| Closed | -$719K | – | 2772 |
|
|
2024
Q2 | $719K | Buy |
+42,841
| New | +$719K | ﹤0.01% | 1647 |
|
|
2024
Q1 | – | Sell |
-28,552
| Closed | -$428K | – | 2491 |
|
|
2023
Q4 | $428K | Buy |
28,552
+1,731
| +6% | +$26K | ﹤0.01% | 1478 |
|
|
2023
Q3 | $376K | Sell |
26,821
-60,059
| -69% | -$841K | ﹤0.01% | 1514 |
|
|
2023
Q2 | $899K | Buy |
86,880
+71,572
| +468% | +$741K | ﹤0.01% | 1403 |
|
|
2023
Q1 | $141K | Buy |
+15,308
| New | +$141K | ﹤0.01% | 1959 |
|
|
2020
Q1 | – | Sell |
-1,769
| Closed | -$59K | – | 2035 |
|
|
2019
Q4 | $59K | Buy |
1,769
+550
| +45% | +$18.3K | ﹤0.01% | 1478 |
|
|
2019
Q3 | $29K | Buy |
+1,219
| New | +$29K | ﹤0.01% | 1528 |
|